acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine

C34H34Br2N10O5 — CID 158380623

IUPACacetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine
SMILESCC(=O)O.COCc1cccc(NC(=O)c2nn(C)c3ncc(Br)cc23)c1N.COCc1cccc2[nH]c(-c3nn(C)c4ncc(Br)cc34)nc12
InChIInChI=1S/C16H16BrN5O2.C16H14BrN5O.C2H4O2/c1-22-15-11(6-10(17)7-19-15)14(21-22)16(23)20-12-5-3-4-9(8-24-2)13(12)18;1-22-16-11(6-10(17)7-18-16)14(21-22)15-19-12-5-3-4-9(8-23-2)13(12)20-15;1-2(3)4/h3-7H,8,18H2,1-2H3,(H,20,23);3-7H,8H2,1-2H3,(H,19,20);1H3,(H,3,4)
InChIKeyJRPBOKMBWAPYLC-UHFFFAOYSA-N
MW822.52 g/mol
LogP6.22
Rot. Bonds7

About acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine

acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine (PubChem CID 158380623) has the molecular formula C34H34Br2N10O5 and a molecular weight of 822.52 g/mol. Its IUPAC name is acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine.

Molecular Properties

Compound Nameacetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine
PubChem CID158380623
Molecular FormulaC34H34Br2N10O5
Molecular Weight822.52 g/mol
Exact Mass820.11
IUPAC Nameacetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine
SMILESCC(=O)O.COCc1cccc(NC(=O)c2nn(C)c3ncc(Br)cc23)c1N.COCc1cccc2[nH]c(-c3nn(C)c4ncc(Br)cc34)nc12
InChIInChI=1S/C16H16BrN5O2.C16H14BrN5O.C2H4O2/c1-22-15-11(6-10(17)7-19-15)14(21-22)16(23)20-12-5-3-4-9(8-24-2)13(12)18;1-22-16-11(6-10(17)7-18-16)14(21-22)15-19-12-5-3-4-9(8-23-2)13(12)20-15;1-2(3)4/h3-7H,8,18H2,1-2H3,(H,20,23);3-7H,8H2,1-2H3,(H,19,20);1H3,(H,3,4)
InChIKeyJRPBOKMBWAPYLC-UHFFFAOYSA-N
XLogP6.22
TPSA200.98 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms51
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500822.52
LogP ≤ 56.22
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine?
The IUPAC name of acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine (CID 158380623) is acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine.
What is the SMILES notation for acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine?
The canonical SMILES for acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine is CC(=O)O.COCc1cccc(NC(=O)c2nn(C)c3ncc(Br)cc23)c1N.COCc1cccc2[nH]c(-c3nn(C)c4ncc(Br)cc34)nc12.
What is the InChIKey of acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine?
The InChIKey is JRPBOKMBWAPYLC-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H16BrN5O2.C16H14BrN5O.C2H4O2/c1-22-15-11(6-10(17)7-19-15)14(21-22)16(23)20-12-5-3-4-9(8-24-2)13(12)18;1-22-16-11(6-10(17)7-18-16)14(21-22)15-19-12-5-3-4-9(8-23-2)13(12)20-15;1-2(3)4/h3-7H,8,18H2,1-2H3,(H,20,23);3-7H,8H2,1-2H3,(H,19,20);1H3,(H,3,4).
What are the key properties of acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine?
acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine has a molecular weight of 822.52 g/mol, XLogP of 6.22, 7 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for acetic acid;N-[2-amino-3-(methoxymethyl)phenyl]-5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;5-bromo-3-[4-(methoxymethyl)-1H-benzimidazol-2-yl]-1-methylpyrazolo[5,4-b]pyridine is sourced from PubChem (CID 158380623), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).